| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
32,653,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile scPharmaceuticals is a pharmaceutical company. Co.'s primary product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infusor and is under development for treatment of congestion in patients with worsening heart failure who display reduced responsiveness to oral diuretics and do not require hospitalization.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
762,380 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,002,495 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
826,622 |
| Total Sell Value |
$0 |
$0 |
$0 |
$3,585,860 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tucker John H |
President and CEO |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
113,560 |
254,207 |
|
- |
|
| Nokes Rachael |
CFO and Treasurer |
• – – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
41,840 |
62,406 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2024-01-02 |
4 |
D |
$6.39 |
$31,579 |
D/D |
(4,942) |
140,647 |
|
- |
|
| Nokes Rachael |
CFO and Treasurer |
• – – |
2024-01-02 |
4 |
D |
$6.39 |
$6,563 |
D/D |
(1,027) |
20,566 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2023-01-19 |
4 |
A |
$6.14 |
$409,323 |
D/D |
66,665 |
145,589 |
|
- |
|
| Nokes Rachael |
See Remarks |
• – – |
2023-01-19 |
4 |
A |
$6.14 |
$71,838 |
D/D |
11,700 |
21,593 |
|
- |
|
| Orbimed Genesis Gp Llc |
10% Owner |
– – • |
2022-11-25 |
4 |
B |
$5.25 |
$4,002,495 |
I/I |
762,380 |
5,328,328 |
1.5 |
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-10-10 |
4 |
S |
$4.09 |
$2,300,486 |
I/I |
(562,466) |
410,268 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2022-10-07 |
4 |
D |
$4.98 |
$51,234 |
D/D |
(10,288) |
78,924 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2022-10-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,250 |
89,212 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-10-06 |
4 |
S |
$5.02 |
$188,421 |
I/I |
(37,534) |
497,304 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-09-07 |
4 |
S |
$4.75 |
$950,000 |
I/I |
(200,000) |
503,112 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-09-06 |
4 |
S |
$5.52 |
$146,953 |
I/I |
(26,622) |
533,285 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-04-11 |
4 |
S |
$5.00 |
$1,350,000 |
I/I |
(270,000) |
537,301 |
|
- |
|
| Khattar Jack A. |
Director |
– • – |
2021-12-03 |
4 |
B |
$3.91 |
$19,569 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Tucker John H |
President and CEO |
• • – |
2021-12-03 |
4 |
B |
$3.96 |
$39,553 |
D/D |
10,000 |
46,962 |
2.81 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2021-03-15 |
4 |
S |
$7.03 |
$777,788 |
I/I |
(110,588) |
2,727,446 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2021-03-12 |
4 |
S |
$7.22 |
$284,816 |
I/I |
(39,469) |
2,838,034 |
|
- |
|
| Nokes Rachael |
See Remarks |
• – – |
2021-02-25 |
4 |
D |
$7.27 |
$14,366 |
D/D |
(1,976) |
9,893 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2020-06-30 |
4 |
D |
$7.36 |
$75,720 |
D/D |
(10,288) |
36,962 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2020-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,250 |
47,250 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2020-05-26 |
4 |
B |
$8.65 |
$4,999,994 |
I/I |
578,034 |
578,034 |
1.5 |
- |
|
| Orbimed Genesis Gp Llc |
10% Owner |
– – • |
2020-05-21 |
4 |
B |
$8.65 |
$11,999,998 |
I/I |
1,387,283 |
231,200 |
1.5 |
- |
|
| Nokes Rachael |
See Remarks |
• – – |
2020-02-25 |
4 |
D |
$10.09 |
$19,988 |
D/D |
(1,981) |
11,869 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-02-14 |
4 |
B |
$8.20 |
$2,230,343 |
I/I |
271,993 |
3,247,005 |
1.5 |
- |
|
44 Records found
|
|
Page 1 of 2 |
|
|
